Roch Thibert
About Roch Thibert
Roch Thibert is the Executive Director of Pharmaceutical R&D at Corealis Pharma Inc., where he has worked since 2013. He has over a decade of experience in pharmaceutical development, including previous roles at Merck and Corealis Pharma.
Current Role at Corealis Pharma
Roch Thibert serves as the Executive Director of Pharmaceutical R&D at Corealis Pharma Inc. He has held this position since 2013. In this role, he oversees research and development initiatives within the pharmaceutical sector, focusing on advancing the company's product pipeline and ensuring compliance with industry standards.
Previous Experience at Corealis Pharma
Before his current role, Roch Thibert worked at Corealis Pharma Inc. as the Senior Director of Pharmaceutical Development from 2009 to 2013. During this time, he contributed to the development of various pharmaceutical products and strategies, enhancing the company's capabilities in drug formulation and delivery.
Experience at Merck
Roch Thibert was employed at Merck as an Associate Director from 1997 to 2007. His tenure at Merck spanned a decade, during which he was involved in various projects related to pharmaceutical development and operational management, contributing to the company's research objectives.
Education in Pharmaceutical Sciences
Roch Thibert earned a Ph.D. in Pharmaceutical Sciences from Université de Montréal. This academic background provided him with a strong foundation in drug development, formulation science, and regulatory affairs, which supports his current and past roles in the pharmaceutical industry.